S&P 500   4,565.19 (+0.32%)
DOW   35,500.84 (+0.47%)
QQQ   390.55 (+0.35%)
AAPL   190.93 (+0.60%)
MSFT   382.79 (+1.10%)
META   336.32 (+0.48%)
GOOGL   136.71 (+0.22%)
AMZN   147.54 (-0.13%)
TSLA   242.20 (+2.59%)
NVDA   481.10 (-0.27%)
NIO   7.24 (+0.70%)
BABA   76.10 (-1.84%)
AMD   122.47 (-0.15%)
T   16.15 (-0.37%)
F   10.37 (+0.29%)
MU   75.66 (-2.39%)
CGC   0.54 (-1.96%)
GE   119.78 (-0.16%)
DIS   94.17 (-1.05%)
AMC   6.67 (-1.91%)
PFE   29.96 (-0.60%)
PYPL   57.27 (+1.56%)
XOM   104.64 (+0.65%)
S&P 500   4,565.19 (+0.32%)
DOW   35,500.84 (+0.47%)
QQQ   390.55 (+0.35%)
AAPL   190.93 (+0.60%)
MSFT   382.79 (+1.10%)
META   336.32 (+0.48%)
GOOGL   136.71 (+0.22%)
AMZN   147.54 (-0.13%)
TSLA   242.20 (+2.59%)
NVDA   481.10 (-0.27%)
NIO   7.24 (+0.70%)
BABA   76.10 (-1.84%)
AMD   122.47 (-0.15%)
T   16.15 (-0.37%)
F   10.37 (+0.29%)
MU   75.66 (-2.39%)
CGC   0.54 (-1.96%)
GE   119.78 (-0.16%)
DIS   94.17 (-1.05%)
AMC   6.67 (-1.91%)
PFE   29.96 (-0.60%)
PYPL   57.27 (+1.56%)
XOM   104.64 (+0.65%)
S&P 500   4,565.19 (+0.32%)
DOW   35,500.84 (+0.47%)
QQQ   390.55 (+0.35%)
AAPL   190.93 (+0.60%)
MSFT   382.79 (+1.10%)
META   336.32 (+0.48%)
GOOGL   136.71 (+0.22%)
AMZN   147.54 (-0.13%)
TSLA   242.20 (+2.59%)
NVDA   481.10 (-0.27%)
NIO   7.24 (+0.70%)
BABA   76.10 (-1.84%)
AMD   122.47 (-0.15%)
T   16.15 (-0.37%)
F   10.37 (+0.29%)
MU   75.66 (-2.39%)
CGC   0.54 (-1.96%)
GE   119.78 (-0.16%)
DIS   94.17 (-1.05%)
AMC   6.67 (-1.91%)
PFE   29.96 (-0.60%)
PYPL   57.27 (+1.56%)
XOM   104.64 (+0.65%)
S&P 500   4,565.19 (+0.32%)
DOW   35,500.84 (+0.47%)
QQQ   390.55 (+0.35%)
AAPL   190.93 (+0.60%)
MSFT   382.79 (+1.10%)
META   336.32 (+0.48%)
GOOGL   136.71 (+0.22%)
AMZN   147.54 (-0.13%)
TSLA   242.20 (+2.59%)
NVDA   481.10 (-0.27%)
NIO   7.24 (+0.70%)
BABA   76.10 (-1.84%)
AMD   122.47 (-0.15%)
T   16.15 (-0.37%)
F   10.37 (+0.29%)
MU   75.66 (-2.39%)
CGC   0.54 (-1.96%)
GE   119.78 (-0.16%)
DIS   94.17 (-1.05%)
AMC   6.67 (-1.91%)
PFE   29.96 (-0.60%)
PYPL   57.27 (+1.56%)
XOM   104.64 (+0.65%)

Can-Fite BioPharma (CANF) Institutional Ownership

$2.31
-0.07 (-2.94%)
(As of 11:39 AM ET)
Compare
Today's Range
$2.24
▼
$2.33
50-Day Range
$1.90
▼
$2.70
52-Week Range
$1.52
▼
$8.74
Volume
14,659 shs
Average Volume
61,671 shs
Market Capitalization
$8.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.00
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for Can-Fite BioPharma (NYSE:CANF)

Current
Institutional Ownership
Percentage
1.54%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$755,700.00
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$9,501.50
Get CANF Insider Trade Alerts

Want to know when executives and insiders are buying or selling Can-Fite BioPharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CANF Institutional Buying and Selling by Quarter


Can-Fite BioPharma Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2023Armistice Capital LLC330,000$0.76M0.0%N/A9.322%
2/15/2023Morgan Stanley304,675$0.19M0.0%-4.8%10.092%
8/13/2022Virtu Financial LLC56,322$52K0.0%N/A0.207%
2/10/2022Acadian Asset Management LLC28,601$36K0.0%-75.1%0.105%
11/16/2021Cetera Advisor Networks LLC130,776$0.22M0.0%-16.9%0.607%
10/15/2021Fifth Third Bancorp30,000$50K0.0%N/A0.149%
8/6/2021StoneX Group Inc.40,000$91K0.0%N/A0.233%
5/21/2021Citadel Advisors LLC60,077$0.15M0.0%N/A0.349%
5/19/2021Virtu Financial LLC46,294$0.11M0.0%-37.5%0.269%
5/18/2021Citadel Advisors LLC60,077$0.15M0.0%N/A0.349%
5/18/2021Jane Street Group LLC10,665$26K0.0%N/A0.062%
5/14/2021XTX Topco Ltd11,205$28K0.0%N/A0.065%
5/14/2021Stifel Financial Corp12,000$30K0.0%N/A0.070%
3/26/2021Susquehanna International Group LLP15,323$27K0.0%N/A0.090%
2/24/2021Virtu Financial LLC74,052$0.13M0.0%+445.7%0.479%
2/10/2021Renaissance Technologies LLC118,894$0.21M0.0%+812.7%0.769%
8/7/2020Virtu Financial LLC31,805$63K0.0%N/A0.206%
2/13/2020Renaissance Technologies LLC32,382$0.11M0.0%N/A2.429%
8/14/2019Morgan Stanley60,981$0.18M0.0%-85.1%4.575%
5/14/2019Taylor Asset Management Inc.538,600$0.47M0.3%-32.4%40.405%
5/13/2019Meitav Dash Investments Ltd.508,630$0.45M0.0%+8.4%2.546%
5/15/2018Anson Funds Management LP1,357,586$1.96M1.5%N/A6.795%
5/15/2018Sabby Management LLC1,228,091$1.77M0.2%N/A6.147%
2/15/2018Meitav Dash Investments Ltd.155,000$0.24M0.0%N/A0.935%
(Data available from 1/1/2016 forward)













CANF Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CANF shares?

During the previous two years, the following institutional investors and hedge funds held shares of Can-Fite BioPharma shares: Armistice Capital LLC ($0.76M), Morgan Stanley ($0.19M), and Virtu Financial LLC ($52K), Acadian Asset Management LLC ($36K).Learn more on CANF's institutional investors.

What percentage of Can-Fite BioPharma stock is owned by institutional investors?

1.54% of Can-Fite BioPharma stock is owned by institutional investors. Learn more on CANF's institutional investor holdings.

Which institutional investors have been buying Can-Fite BioPharma stock?

The following institutional investors have purchased Can-Fite BioPharma stock in the last 24 months: Armistice Capital LLC ($0.33M), and Virtu Financial LLC ($56.32K).

How much institutional buying is happening at Can-Fite BioPharma?

Institutional investors have bought a total of 386,322 shares in the last 24 months. This purchase volume represents approximately $1.33M in transactions.

Which Can-Fite BioPharma major shareholders have been selling company stock?

The following institutional investors have sold Can-Fite BioPharma stock in the last 24 months: Acadian Asset Management LLC ($86.21K), and Morgan Stanley ($15.50K).

How much institutional selling is happening at Can-Fite BioPharma?

Institutional investors have sold a total of 101,706 shares in the last 24 months. This volume of shares sold represents approximately $1.12M in transactions.


Related Companies:
This page (NYSE:CANF) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -